Homar, Francesc; Lozano, Virginia; Martínez-Gómez, Juan; … - In: Health Economics Review 2 (2012) 1, pp. 1-9
Our study suggests that the discontinuation of FDC treatment and the replacement with the administration of separate antiretroviral agents could lead to an increase in healthcare costs due to the higher rate of adverse events that was observed with the discontinuation of FDCs. </AbstractSection> Copyright Homar...